11/21/2024

Janusmed fosterpåverkan

Janusmed fosterpåverkan – warfarin

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
3 3
3 3

Warfarin

Warfarin

Klass : 3

Visa all info

Skriv ut

Kontakta oss

  1. D'Souza R, Ostro J, Shah PS, Silversides CK, Malinowski A, Murphy KE et al. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis. Eur Heart J. 2017;38(19):1509-1516.

  2. Steinberg ZL, Dominguez-Islas CP, Otto CM, Stout KK, Krieger EV. Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women With Mechanical Heart Valves. J Am Coll Cardiol. 2017;69(22):2681-2691.

  3. Cotrufo M, De Feo M, De Santo LS, Romano GP, Della Corte A, Renzulli A et al. Risk of warfarin during pregnancy with mechanical valve prostheses. Obset Gynecol 2002;99:35-40.

  4. Sillesen M, Hjortdal V, Vejlstrup N, Sørensen K. Pregnancy with prosthetic heart valves - 30 years' nationwide experience in Denmark. Eur J Cardiothorac Surg. 2011;40:448-54.

  5. van Driel D, Wesseling J, Sauer PJ et al. Teratogen update: Fetal effects after in utero exposure to coumarins, overview of cases, follow-up findings, and pathogenesis. Teratology 2002;66:127-40.

  6. Wesseling J, van Driel D, Smrkovsky M, ven der Veer E, Geven-Boere LM, Suer PJ et al. Neurological outcome in school-age children after in utero exposure to coumarins. Early Hum Dev 2001;63:83-95.

  7. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol. 1999;33:1637-41.

  8. Iturbe-Alessio I, Fonseca MC, Mutchinik O et al. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 1986;315:1390-3.

  9. Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980;68:122-40.

  10. Barr M, Burdi AR. Warfarin-associated embryopathy in a 17-week-old abortus. Teratology 1976;14:129-34.

  11. Letter: Warfarin and fetal abnormality. Lancet 1976;1:1127.

  1. D'Souza R, Ostro J, Shah PS, Silversides CK, Malinowski A, Murphy KE et al. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis. Eur Heart J. 2017;38(19):1509-1516.
  2. Steinberg ZL, Dominguez-Islas CP, Otto CM, Stout KK, Krieger EV. Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women With Mechanical Heart Valves. J Am Coll Cardiol. 2017;69(22):2681-2691.
  3. Cotrufo M, De Feo M, De Santo LS, Romano GP, Della Corte A, Renzulli A et al. Risk of warfarin during pregnancy with mechanical valve prostheses. Obset Gynecol 2002;99:35-40.
  4. Sillesen M, Hjortdal V, Vejlstrup N, Sørensen K. Pregnancy with prosthetic heart valves - 30 years' nationwide experience in Denmark. Eur J Cardiothorac Surg. 2011;40:448-54.
  5. van Driel D, Wesseling J, Sauer PJ et al. Teratogen update: Fetal effects after in utero exposure to coumarins, overview of cases, follow-up findings, and pathogenesis. Teratology 2002;66:127-40.
  6. Wesseling J, van Driel D, Smrkovsky M, ven der Veer E, Geven-Boere LM, Suer PJ et al. Neurological outcome in school-age children after in utero exposure to coumarins. Early Hum Dev 2001;63:83-95.
  7. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol. 1999;33:1637-41.
  8. Iturbe-Alessio I, Fonseca MC, Mutchinik O et al. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 1986;315:1390-3.
  9. Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980;68:122-40.
  10. Barr M, Burdi AR. Warfarin-associated embryopathy in a 17-week-old abortus. Teratology 1976;14:129-34.
  11. Letter: Warfarin and fetal abnormality. Lancet 1976;1:1127.